Bioequivalance

Completed

Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fasted Conditions

NCT07698275

Conditions

Bioequivalance

Locations

• Axis Clinicals Latina, S.A. de C.V. — Mexico City, Mexico

View Trial Details

Completed

Bioequivalence Study of Vortioxetine in 20 mg Coated Tablets in Healthy Subjects Under Fasting Conditions

NCT07624357

Conditions

Bioequivalance

Locations

• Axis Clinicals Latina, S.A. de C.V. — Mexico City, Mexico

View Trial Details

Completed

An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection

NCT07495007

Conditions

Bioequivalance, Post-menopause

Locations

• Zi Diligence Biocenter — Cairo, Cairo Governorate, Egypt

View Trial Details

Completed

Bioequivalence Study of EMPAGLIFLOZIN (25 mg Tablets) vs. JARDIANCE® (25 mg Tablets), in Healthy Research Subjects, Under Fasting Conditions

NCT07479108

Conditions

Bioequivalance

Locations

• FS Scientia Pharma — San Luis Potosí City, San Luis Potosí, Mexico

View Trial Details

Completed

Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid® at Steady-state.

NCT06773767

Conditions

Bioavailability Heathy Volunteers, Bioavailability Study, Bioequivalance

Locations

• SocraTec R&D GmbH Clinical Pharmacology — Erfurt, Germany

View Trial Details

Completed

Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects

NCT04155814

Conditions

Bioequivalance

Locations

• Baxter Investigational Site — Miami, Florida, United States

View Trial Details